ISOL is the World's Premiere CBD Company ISOL is going to have an epic 2018, Isodiol just got added to MJX, the ETFMG Alternative Harvest ETF.
Plus ISOL is now involved in California, here's today's news
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aISOL-2552055&symbol=ISOL®ion=C
Plus Isodiol has 50 Million in cash Plus the company has Zero Debt and a Revenue forecast of 60M+ USD for 2018.
Isodiol International is the market leader in pharmaceutical-grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products. Isodiol is the pioneer of many firsts for the cannabis industry, including commercialization of 99-per-cent-plus-pure, bioactive pharmaceutical-grade cannabinoids, microencapsulations, and nanotechnology for the highest-quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs and expanding its phytoceutical portfolio, and it will aggressively continue international expansion into Latin America, Asia and Europe.
Here's a 20 Page Report written up by Fundamental Research, which is giving ISOL a $2.59 U.S a share Fair Value price Target.
https://bit.ly/2paPCeA Here's more proof below that ISOL is still very undervalued in comparison to its market peers in the sector.
ISOL is 6th in revenue for Cannabis stocks trading in Canada. This was put out by new Cannabis Ventures about a week ago. In it you will see ISOL just below APH.
https://www.newcannabisventures.com/public-cannabis-company-revenue-tracker-provides-updates-through-december-4-2017/